[HIV infection and Lyell syndrome: a wake-up call concerning anti-inflammatory agents].
de Luis
D A
DA
Fortun
J
J
Pintado
V
V
Aller de la Fuente
R
R
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001228:Aspergillosis / Q000150:complications; D004008:Diclofenac / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000150:complications; D010894:Piroxicam / Q000009:adverse effects*; D011739:Pyrimethamine / Q000009:adverse effects; D013262:Stevens-Johnson Syndrome / Q000209:etiology*; D013411:Sulfadiazine / Q000009:adverse effects; D016781:Toxoplasmosis, Cerebral / Q000150:complications / Q000188:drug therapy
D000894:Anti-Inflammatory Agents, Non-Steroidal; D013411:Sulfadiazine; D010894:Piroxicam; D004008:Diclofenac; D011739:Pyrimethamine